Inactive Instrument
BiVictriX Therapeutics plc Stock
Stocks
BVX
GB00BNXH3K91
Biotechnology & Medical Research
OTC Markets Traded| 1 day | +17.65% |
| Manager | Title | Age | Since |
|---|---|---|---|
Tiffany Thorn
CEO | Chief Executive Officer | 39 | 2015-12-31 |
Adrian Howd
DFI | Director of Finance/CFO | 54 | 2023-10-02 |
Alison Halsall
SEC | Corporate Secretary | - | 2023-10-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Tiffany Thorn
BRD | Director/Board Member | 39 | 2015-12-31 |
Susan Lowther
BRD | Director/Board Member | 67 | 2021-09-21 |
William Paris
BRD | Director/Board Member | 75 | 2021-09-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24-09-01 | Buy | Director | 20,000 | 0.0242% | ||
| 24-09-01 | Sell | Director | 20,000 | 0.0242% | ||
| 24-08-12 | Free | Director | 200,000 | 0.2423% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +17.65% | +33.33% | - | - | 10.49M | |
| +1.01% | +2.44% | +3.30% | +11.28% | 50.44B | |
| +0.72% | +1.00% | +396.18% | +624.25% | 40.63B | |
| +2.54% | +0.93% | +28.98% | -3.62% | 34.88B | |
| +0.31% | +1.74% | +18.44% | +59.76% | 33.67B | |
| -2.09% | -1.98% | +3.21% | +33.56% | 26.29B | |
| -0.63% | +0.34% | - | - | 17.11B | |
| +0.66% | -3.96% | +66.85% | +127.36% | 15.29B | |
| -23.90% | -21.43% | +50.06% | +53.83% | 10.62B | |
| +1.25% | +0.43% | +14.91% | +22.34% | 13.74B | |
| Average | -0.20% | -2.71% | +72.74% | +116.10% | 26.96B | |
| Weighted average by Cap. | -0.39% | -0.61% | +87.51% | +139.78% |
Employees
15
Choose MarketScreener 
